CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 38 enrolled
Drug / intervention
Imagiodevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05022602
NCT05022602N/ACompleted
CompareCT.gov

Clinical Evaluation of Opto-Acoustic Image Quality With the Gen 2 Imagio System

Seno Medical Instruments Inc.·interventional·Posted Aug 26, 2021·Updated Mar 29, 2023

In Brief

A clinical study evaluating Imagio for Breast Cancer Stage. Completed, enrolled 38 participants across 1 site.

Detailed Summary

This study performs the first clinical evaluation of the Gen 2 Imagio System in a clinical setting to assess image quality with both the IUS ultrasound only probe and the OA/US (duplex probe).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer Stage
CountriesUnited States
CollaboratorsAmerican College of Radiology

Timeline

N/ACompletedFinished
20222023202420252026
First PostedAug 26, 2021
Enrollment StartAug 19, 2021
Primary CompletionFeb 17, 2022
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 4.9 years ago

Interventions

Imagiodevice

Imagio - both ultrasound probe and Duplex OA probe